[Hypercoagulation syndrome in multiple myeloma].
Е С Урнова, Л. П. Менделеева(National Research Center for Hematology Russian Academy of Medical Sciences), Э Г Гемджян(National Medical Research Center for Hematology), О. С. Покровская, С. А. Васильев, Marina A. Gracheva(Ministry of Health of the Russian Federation), И. Д. Тарандовский
PubMed
January 1, 2014
Cited by 3
Related Papers
Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation
|Bone Marrow Transplantation|2014|195
Atlas of RNA sequencing profiles for normal human tissues
|Scientific Data|2019|142
Current Multiple Myeloma Treatment Strategies with Novel Agents: A European Perspective
|The Oncologist|2010|92
Thromboelastography, thrombin generation test and thrombodynamics reveal hypercoagulability in patients with multiple myeloma
|Leukemia & lymphoma/Leukemia and lymphoma|2015|59